MiNK Therapeutics, Inc. (NASDAQ: INKT) reported Q2 EPS of ($0.07), $0.03 better than the analyst estimate of ($0.10).

For earnings history and earnings-related data on MiNK Therapeutics, Inc. (INKT) click here.